| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.48B | 12.14B | 12.55B | 15.79B | 11.78B | 7.50B |
| Gross Profit | 1.05B | 1.96B | 2.22B | 4.07B | 3.50B | 1.02B |
| EBITDA | 483.00M | 2.21B | 1.96B | 4.18B | 3.69B | 1.25B |
| Net Income | -957.00M | 602.00M | 479.00M | 2.25B | 2.02B | 330.00M |
Balance Sheet | ||||||
| Total Assets | 19.81B | 20.75B | 21.04B | 20.55B | 18.46B | 13.84B |
| Cash, Cash Equivalents and Short-Term Investments | 2.13B | 2.92B | 3.30B | 2.23B | 1.91B | 1.31B |
| Total Debt | 5.37B | 5.28B | 5.52B | 5.38B | 5.64B | 3.95B |
| Total Liabilities | 9.88B | 9.71B | 10.27B | 10.09B | 9.93B | 7.26B |
| Stockholders Equity | 9.43B | 10.53B | 10.24B | 9.93B | 7.96B | 6.04B |
Cash Flow | ||||||
| Free Cash Flow | -365.00M | 306.00M | 1.30B | 2.29B | 1.74B | 772.00M |
| Operating Cash Flow | 674.00M | 1.31B | 2.34B | 3.40B | 2.39B | 1.30B |
| Investing Cash Flow | -1.23B | -1.00B | -1.04B | -2.48B | -3.21B | -509.00M |
| Financing Cash Flow | -418.00M | -650.00M | -245.00M | -587.00M | 1.44B | -216.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $17.46B | 35.18 | 9.87% | ― | -10.07% | ― | |
67 Neutral | $7.26B | 10.61 | 12.24% | 5.11% | -3.33% | -19.59% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | $15.43B | -82.08 | -0.21% | 1.24% | -23.92% | 90.47% | |
52 Neutral | $9.41B | ― | -9.48% | 2.87% | -5.32% | -1108.29% | |
52 Neutral | $13.83B | -11.43 | -10.44% | 12.57% | -19.65% | -157.13% | |
45 Neutral | $7.64B | ― | -1.48% | ― | -3.59% | -126.16% |
On November 10, 2025, Westlake Corporation announced the pricing and results of its cash tender offer for its outstanding 3.600% Senior Notes due 2026. The tender offer, which expired on the same day, was conducted to manage the company’s debt profile and financial strategy, with the settlement expected around November 12, 2025. This move is part of Westlake’s broader financial management efforts, potentially impacting its market positioning and stakeholder interests by optimizing its capital structure.
On November 4, 2025, Westlake Corporation announced the pricing of its $1.2 billion public offering of senior unsecured notes, with $600 million due in 2035 and another $600 million due in 2055. The proceeds from this offering are intended to repurchase outstanding senior notes due in 2026 and fund the acquisition of ACI/Perplastic Group’s global compounding solutions business, as well as for general corporate purposes. The offering is expected to close on November 6, 2025, and is not contingent upon the completion of the acquisition or the tender offer.
On November 4, 2025, Westlake Corporation announced the commencement of a cash tender offer to purchase any and all of its outstanding 3.600% Senior Notes due 2026. The tender offer aims to extend the maturity of Westlake’s outstanding indebtedness and is contingent upon the successful completion of a concurrent senior notes offering. The offer is set to expire on November 10, 2025, and Westlake plans to fund the purchase of the notes with the net proceeds from the notes offering, potentially impacting the company’s financial structure and market positioning.
Westlake Corporation reported its third quarter 2025 financial results, revealing a net loss of $782 million due to a significant non-cash impairment charge related to its North American chlorovinyls business. The company’s EBITDA, excluding identified items, decreased compared to both the previous quarter and the same quarter in 2024, primarily due to lower sales prices and volumes in its Performance and Essential Materials segment, as well as administrative and restructuring expenses in its Housing and Infrastructure Products segment.